Here's Why CBOE Global (CBOE) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CBOE - Cboe Global Markets, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$313.33
DETAILS
HIGH:
$347.00
LOW:
$258.00
MEDIAN:
$318.50
CONSENSUS:
$313.33
UPSIDE:
16.88%
Stock News
Cboe expects SK Hynix options to trade two business days after Nasdaq debut, source says
Derivatives exchange Cboe Global Markets expects to list options on SK Hynix's U.S.-listed shares two business days after the stock's trading debut, a source familiar with the matter told Reuters on Friday.
Will CBOE (CBOE) Beat Estimates Again in Its Next Earnings Report?
CBOE (CBOE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
LANGAR INVESTMENT MANAGEMENT ANNOUNCES TRANSFER OF THE LANGAR GLOBAL HEALTHTECH ETF TO THE CBOE BZX EXCHANGE
LOS ANGELES, July 7, 2026 /PRNewswire/ -- Langar Investment Management LLC, the adviser to the Langar Global HealthTech ETF (NYSE Arca: LGHT), today announced the transfer of the primary listing of LGHT from NYSE Arca to the Cboe BZX Exchange on or about June 29, 2026. Current shareholders of LGHT are not required to take any action, nor is the transfer expected to have any effect on the trading of the Fund's shares.
Here's Why Cboe Global's Revenue Growth Is More Than a Trading Story
Cboe Global's revenue growth extends beyond trading, powered by options strength, recurring data services, global expansion and a diversified revenue mix.
Cboe Global Stock Lags Industry, Trades at a Discount: Time to Buy?
Cboe Global's discounted valuation, diversified revenues, higher growth targets and bullish estimates make the stock look compelling.
Corgi Launches 24 ETFs on Cboe BZX: 15 Leveraged 2x Daily ETFs and Nine July Series Structured Buffer ETFs
Corgi lists 14 single-stock 2x Daily ETFs plus the Corgi Quantum Computing 2x Daily ETF on June 30, each at a 0.45% expense ratio and the lowest net expense ratio of any U.S.-listed 2x daily long ETF tracking the same underlying,* and nine July Series Structured Buffer ETFs on July 2, offering built-in downside buffers at a gross expense ratio of 0.40% and net expense ratio of 0.30%.** NEW YORK, July 2, 2026 /PRNewswire/ -- Corgi, an AI fintech startup, announced the launch and listing of 24 ETFs on Cboe BZX Exchange across two product lines this week: 15 leveraged 2x Daily ETFs on June 30 and nine July Series Structured Buffer ETFs on July 2.
Best Growth Stocks to Buy for July 1st
ALH, CBOE, and DK it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 1, 2026.
Rolling Into Spreads: Extend Profit Potential with Lower Risk
Learn how a vertical spread options strategy can help reduce risk, lock in gains, and stay invested in winning trades.
Cboe Canada Welcomes Listing of GuideAI Health Corp.
TORONTO--(BUSINESS WIRE)---- $GDAI #Cboe--Cboe Canada announces the listing of GuideAI Health Corp., trading under the symbol GDAI.
Best Growth Stocks to Buy for June 29th
CLS, CBOE, and CNC it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2026.
Is CBOE (CBOE) a Solid Growth Stock? 3 Reasons to Think "Yes"
CBOE (CBOE) could produce exceptional returns because of its solid growth attributes.
Cboe CEO Craig Donohue on derivatives: Allowing investors to protect and hedge their investments
Craig Donohue, Cboe Global Markets CEO, joins 'The Exchange' to discuss the importance of the Cboe, the derivatives portion of equity markets and much more.
Cboe Canada Welcomes Listing of Hamilton Enhanced Bitcoin DayMAX™ ETF (BDAY)
TORONTO--(BUSINESS WIRE)---- $BDAY #Cboe--Cboe Canada announces the listing of the Hamilton Enhanced Bitcoin DayMAX™ ETF.
Buy These 5 Low-Leverage Stocks Amid Widespread Tech Sell-Off
Five low-leverage stocks stand out as investors rotate from tech, with earnings growth, expansion plans and strategic updates supporting interest.
After Plunging 28.2% in 4 Weeks, Here's Why the Trend Might Reverse for CBOE (CBOE)
The heavy selling pressure might have exhausted for CBOE (CBOE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Best Growth Stocks to Buy for June 25th
CBOE, CNC and CRDO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 25th, 2026.
Cboe Introduces Cboe Predicts, Launching First Products in New Prediction Markets Suite
CHICAGO, June 23, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced the launch of the first products in its new prediction markets suite, Cboe PredictsSM. The offering includes binary option contracts based on the Mini-S&P 500 Index (XSP), listed under the symbols XSPBW and XSPBX.
CBOE Stock Plunges 28.4% in a Month: Time to Buy the Dip?
Cboe Global leverages record derivatives activity, data services growth and portfolio optimization to fuel long-term expansion.
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork ), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.
Price Targets
Cboe Global Markets price target lowered to $258 from $273 at Morgan Stanley
$258.00
(was $267.92)
Michael Cyprys
·
Morgan Stanley
Cboe Global Markets price target lowered to $347 from $382 at Barclays
$347.00
(was $263.86)
Loop Capital Markets
Cboe Global Markets price target lowered to $263 from $365 at TD Cowen
$263.00
(was $250.96)
Loop Capital Markets
Cboe price target lowered to $316 from $331 at Rothschild & Co Redburn
$316.00
(was $301.08)
Redburn Partners
Cboe Global Markets price target raised to $340 from $330 at BofA
$340.00
(was $339.36)
Loop Capital Markets
Cboe Global Markets price target raised to $335 from $305 at UBS
$335.00
(was $338.76)
UBS
Cboe Global Markets price target raised to $395 from $355 at Deutsche Bank
$395.00
(was $335.05)
Loop Capital Markets
Cboe Global Markets price target raised to $365 from $293 at TD Cowen
$365.00
(was $337.25)
Loop Capital Markets
Cboe Global Markets price target raised to $335 from $300 at Keefe Bruyette
$335.00
(was $326.96)
Loop Capital Markets
Cboe Global Markets price target raised to $382 from $351 at Barclays
$382.00
(was $326.96)
Loop Capital Markets
Cboe Global Markets price target raised to $321 from $295 at Piper Sandler
$321.00
(was $300.75)
Piper Sandler
Cboe Global Markets price target raised to $273 from $246 at Morgan Stanley
$273.00
(was $294.05)
Michael Cyprys
·
Morgan Stanley
Cboe Global Markets price target raised to $293 from $284 at TD Cowen
$293.00
(was $294.82)
Loop Capital Markets
Cboe Global Markets price target raised to $303 from $280 at RBC Capital
$303.00
(was $275.82)
Ashish Sabadra
·
RBC Capital
Cboe Global Markets price target raised to $290 from $280 at UBS
$290.00
(was $275.36)
Alex Kramm
·
UBS
Cboe Global Markets price target raised to $317 from $295 at Barclays
$317.00
(was $273.09)
Benjamin Budish
·
Loop Capital Markets
Cboe Global Markets price target raised to $281 from $274 at TD Cowen
$281.00
(was $262.18)
Loop Capital Markets
Cboe Global Markets price target raised to $295 from $290 at Piper Sandler
$295.00
(was $266.77)
Patrick Moley
·
Piper Sandler
Cboe Global Markets price target lowered to $295 from $302 at Barclays
$295.00
(was $255.16)
Benjamin Budish
·
Loop Capital Markets
Cboe Global Markets price target raised to $280 from $265 at UBS
$280.00
(was $255.25)
UBS